South Carolina § 44-137-20 Availability to eligible patients of investigational drug, biological product, or device; compensation; costs.

South Carolina Statutes

§ 44-137-20 — Availability to eligible patients of investigational drug, biological product, or device; compensation; costs.

South Carolina § 44-137-20

Title 44HEALTH

Ch. 137RIGHT TO TRY ACT

This text of South Carolina § 44-137-20 (Availability to eligible patients of investigational drug, biological product, or device; compensation; costs.) is published on Counsel Stack Legal Research, covering South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.C. Code Ann. § 44-137-20 (2026).

Text

(A)A manufacturer of an investigational drug, biological product, or device may make available to an eligible patient, and an eligible patient may request, the manufacturer's investigational drug, biological product, or device. Nothing in this article shall be construed to require a manufacturer of an investigational drug, biological product, or device to make such investigational drug, biological product, or device available to an eligible patient.

(B)A manufacturer of an investigational drug, biological product, or device may provide the investigational drug, biological product, or device to an eligible patient without receiving compensation or may require the eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological pro

Free access — add to your briefcase to read the full text and ask questions with AI

(A) A manufacturer of an investigational drug, biological product, or device may make available to an eligible patient, and an eligible patient may request, the manufacturer's investigational drug, biological product, or device. Nothing in this article shall be construed to require a manufacturer of an investigational drug, biological product, or device to make such investigational drug, biological product, or device available to an eligible patient. (B) A manufacturer of an investigational drug, biological product, or device may provide the investigational drug, biological product, or device to an eligible patient without receiving compensation or may require the eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.